Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2023 | Acute leukemias of ambiguous lineage: challenges and approaches

Ilaria Iacobucci • 7 Sep 2023
SOHO 2023
Leukemia Rare Diseases

Ilaria Iacobucci, PhD, St. Jude Children’s Research Hospital, Memphis, TN, describes the challenges associated with the characterization and treatment of acute leukemias of ambiguous lineage (ALAL). Dr Iacobucci also comments on the benefit of genomics in allowing identification of specific genetic aberrations and cell populations. This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Ilaria Iacobucci

3:59
Single-cell transcriptomic analysis of B-ALL: leukemia cell state and genetic alterations
Ilaria Iacobucci • 11 Dec 2023
1:50
Current and emerging treatment options for Ph-like ALL
Ilaria Iacobucci • 7 Sep 2023
2:15
Challenges in diagnosing and treating Ph-like ALL
Ilaria Iacobucci • 7 Sep 2023
2:55
Prognostic drivers in AML and MDS
Ilaria Iacobucci • 7 Dec 2019

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals